Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +25.00%
#4 Fabric Protocol Fabric Protocol +18.82%
#5 Velvet Velvet +18.00%
#6 Nockchain Nockchain +14.91%
#7 Perle Perle +13.33%
#8 Bedrock Bedrock +13.11%
#9 Versatize Coin Versatize Coin +12.50%
#10 Starpower Starpower +11.37%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Aceragen, Inc. Aceragen, Inc.

Aceragen, Inc.

ACGN
Rank in Stocks #39036
Aceragen, Inc., a biopharmaceutical firm in its clinical development phase,... Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.
Share Price
$0.38
Last synced: 2023-09-01
Market Cap
$677.16K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aceragen, Inc. (ACGN)

Category

Healthcare
Stock split history for Aceragen, Inc. (ACGN)
Aceragen, Inc. stock (symbol: ACGN) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 15, 2026.
One ACGN share bought prior to Aug 15, 2026 would equal to 0 ACGN shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE